Bloomberg: Athenahealth has five potential bidders

Athenahealth, a network-enabled services company for hospitals and ambulatory clients, has bids from at least five entities, according to a report from Bloomberg. The bidders include Bain Capital, Hellman and Friedman, Clayton, Dubiliar & Rice and TPG.

Elliott Management Corp., which currently owns 9 percent of Athenahealth, is also reportedly considering a bid, according to Bloomberg.

The potential sale of Athenahealth comes after its CEO Jonathan Bush announced he was leaving the company in June after admitting to domestic violence allegations against his former wife.

Final bids are due by the end of the month for the company, though Elliott previously said in May it was prepared to make an offer for $160 per share—above the reported new bids of $135 per share. That previous deal was rumored to be worth around $7 billion.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup